Charles M. Diker Sells 13,000 Shares of Cantel Medical Corp. (CMD) Stock
Cantel Medical Corp. (NYSE:CMD) Chairman Charles M. Diker sold 13,000 shares of the business’s stock in a transaction that occurred on Monday, June 12th. The shares were sold at an average price of $76.36, for a total transaction of $992,680.00. Following the completion of the sale, the chairman now directly owns 3,124,222 shares in the company, valued at $238,565,591.92. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.
Cantel Medical Corp. (NYSE:CMD) last announced its quarterly earnings data on Thursday, June 8th. The company reported $0.51 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.51. The business had revenue of $192.10 million for the quarter, compared to analyst estimates of $193.84 million. Cantel Medical Corp. had a net margin of 9.50% and a return on equity of 17.75%. Cantel Medical Corp.’s revenue was up 10.6% on a year-over-year basis.
TRADEMARK VIOLATION NOTICE: “Charles M. Diker Sells 13,000 Shares of Cantel Medical Corp. (CMD) Stock” was first reported by American Banking News and is the property of of American Banking News. If you are viewing this article on another domain, it was stolen and reposted in violation of U.S. and international trademark and copyright laws. The correct version of this article can be viewed at https://www.americanbankingnews.com/2017/06/13/charles-m-diker-sells-13000-shares-of-cantel-medical-corp-cmd-stock.html.
A number of equities research analysts have recently issued reports on the stock. Needham & Company LLC reissued a “hold” rating on shares of Cantel Medical Corp. in a research note on Thursday, June 8th. Benchmark Co. downgraded shares of Cantel Medical Corp. from a “buy” rating to a “hold” rating in a research note on Friday. Zacks Investment Research downgraded shares of Cantel Medical Corp. from a “hold” rating to a “sell” rating in a research note on Monday, June 5th. Finally, Raymond James Financial, Inc. assumed coverage on shares of Cantel Medical Corp. in a research note on Friday, March 17th. They issued a “market perform” rating on the stock.
About Cantel Medical Corp.
Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.
Receive News & Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related companies with MarketBeat.com's FREE daily email newsletter.